Pharma News – 9 July 2020 Updates
Table of Contents Pharma news – 9 July 2020 Mylan gears up to sell its generic version of Remdesivir at […]
Pharma News
Pharma news – 5 July 2020
Indian Government is reviewing the use of Remdesivir for Covid-19 following reports of liver damage The Union Health Ministry of
Pharma News – 2 July 2020
Sun Pharma launches Ilumya in the Japanese market Sun Pharma had announced the launch of its psoriasis drug, Ilumya, in
Pharma News – 28 June 2020
1. Hindustan Antibiotic’s moves to explore opportunities in line with self-reliant India Around 70% of the active pharmaceutical ingredients (API)
Pharma news – 25 June 2020
India plans to reduce the import of API and other raw materials from China The military face-off between India and
Pharma News – 22 June 2020
Glenmark gets USFDA approval for its Fingolimod capsules: Glenmark Pharmaceuticals received the USFDA’s[1] approval for manufacturing the generic version of
Pharma News – 18 June 2020
USFDA revokes the special status given to Hydroxychloroquine for treating Covid-19 In March 2020, the US[1] president, Donald Trump began
Pharma news – June 20 Updates
Gilead signs licensing pacts with four more drug firms for manufacturing Remdesivir Pharma news – June 20: Gilead Sciences Ltd
Pharma News Updates – June 11, 2020
Indian Government lifts ban on the export of Hydroxychloroquine Pharma news – June 11: On 25 March 2020, the Indian
Pharma news – 8 June, 2020
Sun pharma starts phase 2 clinical trials of a plant-derived drug for Covid-19 The phytopharmaceutical (plant-derived) drug, Aquilegia chrysantha (AQCH)